Insulin-like growth factors and aging

Area of Science:

• Endocrinology
• Molecular Biology
• Aging Research

Background:

• The somatomedin hypothesis posits that growth hormone (GH) acts via insulin-like peptides.
• Insulin-like growth factors I and II (IGF-I and IGF-II) mediate GH's somatotropic actions.
• These factors interact with specific plasma membrane receptors on target cells.

Purpose of the Study:

• To review the evidence supporting the somatomedin hypothesis.
• To examine the roles of IGF-I and IGF-II in human growth and aging.
• To compare the growth hormone-somatomedin axis dynamics in humans and rats.

Main Methods:

• Review of existing scientific literature on the somatomedin hypothesis and IGFs.
• Analysis of human and rat studies investigating growth hormone and IGF levels.
• Comparison of IGF-I and IGF-II dynamics across different life stages and species.

Main Results:

• Circulating IGF-I levels correlate with GH secretion, peaking during adolescence and declining with age.
• IGF-I is implicated in adolescent growth spurts, while IGF-II plays a role in fetal development.
• Rat IGF-II levels decrease significantly post-birth, unlike in humans, suggesting species-specific roles.

Conclusions:

• The somatomedin hypothesis is well-supported, with IGF-I and IGF-II mediating GH actions.
• Age-related decline in GH may contribute to reduced IGF-I levels in older adults.
• While the rat model offers insights, a definitive link between somatomedins and aging remains elusive in both species.